全文获取类型
收费全文 | 53769篇 |
免费 | 3682篇 |
国内免费 | 5284篇 |
出版年
2023年 | 848篇 |
2022年 | 899篇 |
2021年 | 1489篇 |
2020年 | 1501篇 |
2019年 | 2002篇 |
2018年 | 1777篇 |
2017年 | 1428篇 |
2016年 | 1463篇 |
2015年 | 1768篇 |
2014年 | 2866篇 |
2013年 | 3801篇 |
2012年 | 2493篇 |
2011年 | 2891篇 |
2010年 | 2306篇 |
2009年 | 2687篇 |
2008年 | 2854篇 |
2007年 | 3025篇 |
2006年 | 2924篇 |
2005年 | 2662篇 |
2004年 | 2397篇 |
2003年 | 2210篇 |
2002年 | 1965篇 |
2001年 | 1509篇 |
2000年 | 1299篇 |
1999年 | 1212篇 |
1998年 | 1010篇 |
1997年 | 863篇 |
1996年 | 835篇 |
1995年 | 848篇 |
1994年 | 806篇 |
1993年 | 625篇 |
1992年 | 549篇 |
1991年 | 478篇 |
1990年 | 401篇 |
1989年 | 299篇 |
1988年 | 308篇 |
1987年 | 275篇 |
1986年 | 225篇 |
1985年 | 306篇 |
1984年 | 463篇 |
1983年 | 345篇 |
1982年 | 346篇 |
1981年 | 248篇 |
1980年 | 225篇 |
1979年 | 187篇 |
1978年 | 150篇 |
1977年 | 143篇 |
1976年 | 137篇 |
1975年 | 101篇 |
1973年 | 106篇 |
排序方式: 共有10000条查询结果,搜索用时 62 毫秒
1.
2.
3.
目的:探讨癌基因Src在体外培养骨肉瘤细胞侵袭伪足形成中的作用。方法:构建Src sh RNA慢病毒表达载体,在HEK293T细胞中包装慢病毒,感染HT-1080骨肉瘤细胞,经嘌呤霉素加压筛选,获得稳定沉默Src基因的骨肉瘤细胞系HT-1080-sh Src;实时定量PCR和Western Blot法检测基因沉默效率;采用原位明胶酶谱法检测侵袭伪足形成;采用侵袭小室实验检测下调Src基因表达对HT-1080细胞侵袭力的影响。结果:成功构建稳定沉默Src基因的骨肉瘤细胞系HT-1080-sh Src及对照细胞系HT-1080-shluc,经实时定量PCR和Western Blot检测,与对照细胞系相比,HT-1080-sh Src细胞中Src基因表达下调3倍以上;下调HT-1080细胞中Src基因表达能显著抑制HT-1080细胞侵袭伪足形成及其对细胞外基质的降解能力;下调Src基因表达能显著抑制骨肉瘤细胞侵袭力。结论:癌基因Src参与调节骨肉瘤细胞HT-1080侵袭伪足形成,促进肿瘤侵袭、转移。 相似文献
4.
5.
6.
《Bioorganic & medicinal chemistry》2014,22(3):1201-1207
Human rhinoviruses (HRVs) are the most common cause of viral respiratory infections and their complications. So far, no anti-viral agent has been approved for prevention or treatment of HRV infections. Pursuing our researches on small molecules with anti-rhinovirus activity, in this paper we describe the synthesis and in vitro anti-HRV 1B and 14 properties of new [2-(2H-chromen-3-yl)vinyl]pyridines and 3-[2-(pyridinyl)vinyl]-4H-chromen-4-ones. Generally, the synthesized compounds interfered with the replication of both serotypes at the micromolar or submicromolar concentrations. Preliminary results on their mechanism of action, performed on selected (E)-2-[2-(2H-chromen-3-yl)vinyl]pyridine, indicate an interference with the early step(s) of HRV 1B and 14 replication, probably at the uncoating level. 相似文献
7.
Neven Zarkovic Zoran Ilic Mislav Jurin R. Jrg Schaur Herbert Puhl Hermann Esterbauer 《Cell biochemistry and function》1993,11(4):279-286
The aim of this study was to analyze the growth response of HeLa cells over a prolonged period of time to a single exposure of physiological and supraphysiological concentrations of 4-hydroxynonenal (HNE), a peroxidation product of omega-6-polyunsaturated fatty acids. Furthermore, the growth modulating effect of serum factors, particularly albumin, on the growth pattern was examined. The effects of HNE on the growth rate and viability of the cells, as well as on the incorporation of labelled amino acids were monitored daily over a period of four days. Fetal calf serum not only had a growth stimualting effect but also modulated the action of HNE. In neither respect was albumin able to substitute for serum indicating that the influence of serum was not exerted via an albumin–HNE conjugate. HNE had a clear dose-dependent effect and a distinction could be made between a supraphysiological concentration (100 μM), which was primarily cytotoxic and a physiological range (below 10 μM) which showed growth modulatory effects. These effects consisted of a transient inhibition in the initial phase of the cell growth, which under optimal conditions (in presence of serum) was followed by a period of increased proliferation, compared to untreated control cultures, until confluence was attained. It is suggested that HNE is not only a toxic product of lipid peroxidation, but a physiological growth regulating factor as well. 相似文献
8.
An essential part in the development of informative linkage maps is to include genetic markers that have been anchored by physical mapping. Here a set of 18 porcine cosmid-derived genetic markers are reported that have been mapped by linkge analysis, and that also have been physically localized by fluorescence in situ hybridization (FISH). Three different strategies were used to establish polymorphic markers from the cosmid clones. Firstly, dinucleotide microsatellite loci were derived by sequencing cosmid subclones containing (CA), repeats. Secondly, variable SINE 3′ poly(A) tracts (SINEVA) were identified by direct SINE-PCR amplification of cosmid clones. Thirdly, the cosmids were used in Southern blot hybridization to detect restriction fragment length polymorphisms (RFLPs). Compared with the most recent consensus compilation of the porcine gene map, the present assignment of markers to chromosomes Zp, 3, 4, 10, 12q, and 16 represents the first loci mapped to these chromosomes, for which linkage as well as in situ data are now available. 相似文献
9.
10.
Rongsheng Chen Xiaobo Zhang Changsheng Wang 《Journal of cellular biochemistry》2020,121(10):4043-4051
Multiple myeloma (MM) is defined as the second most common hematological tumor in the globe. Long noncoding RNAs (lncRNAs) have been reported to play stimulative or suppressive role in the progression of different carcinomas. The investigation of lncRNAs in MM is still inadequate. LncRNA HOXB cluster antisense RNA 1 (HOXB-AS1) was once revealed to facilitate glioma progression by affecting cellular activities of glioma cells. However, whether HOXB-AS1 participates in the development of MM still remains an enigma. In this study, we unveiled that HOXB-AS1 was highly expressed in MM and loss-of-function assays certified that HOXB-AS1 obstruction suppressed MM cell proliferation, and stimulated cell apoptosis. In addition, HOXB-AS1 could modulate fucosyltransferase 4 (FUT4) and FUT4-mediated Wnt/β-catenin pathway. In subsequence, it was observed from mechanism assays that HOXB-AS1 enhanced the interaction between ELAVL1 and FUT4 so as to stabilize FUT4 messenger RNA. In the end, rescue experiments affirmed that HOXB-AS1 affected the cell growth through FUT4 in MM. In conclusion, the whole modulation mechanism of HOXB-AS1/ELAVL1/FUT4 axis in MM was validated in this study, which suggested that HOXB-AS1 might function as a powerful and promising therapeutic biomarker for the clinical treatment of patients with MM. 相似文献